✨ Medicine Consent and Trade Name Removal
NEW ZEALAND GAZETTE, No. 95 — 20 OCTOBER 2016
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Revolade
Eltrombopag olamine 31.9mg equivalent to eltrombopag 25mg
Film coated tablet
Novartis New Zealand Limited
Glaxo Operations UK Limited (trading as Glaxo Wellcome Operations), Ware, United Kingdom
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Revolade
Eltrombopag olamine 63.8mg equivalent to eltrombopag 50mg
Film coated tablet
Novartis New Zealand Limited
Glaxo Operations UK Limited (trading as Glaxo Wellcome Operations), Ware, United Kingdom
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Revolade
Eltrombopag olamine 95.7mg equivalent to eltrombopag 75mg
Film coated tablet
Novartis New Zealand Limited
Glaxo Operations UK Limited (trading as Glaxo Wellcome Operations), Ware, United Kingdom
Dated this 14th day of October 2016.
SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Removal of Trade Name Products From the Register of Trade Name Products
(Notice No. MPI 696)
Pursuant to section 22(3)(b) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”), I hereby give notice that the products listed in the Annex have been removed from the Register of Trade Name Products and that the registration of these products, as trade name products, has expired or been cancelled.
The importation of the products listed in the Annex are otherwise prohibited from the date of the publication of this notice.
Pursuant to section 22(3)(c) of the Act, any removed product as listed in the Annex may continue to be sold and used (but not manufactured) until 20 October 2017, but not at any time after that date.
Annex
| Trade Name Product | Registration Number |
|---|---|
| 1.0% 1080 WASP PASTE | P003660 |
| AGMAX ANTI-BLOAT NO.2 | A006268 |
| AGMAX ANTI-BLOAT PLUS | A006887 |
| Agmax Levamisole Pour On | A010804 |
| ALBAC 150 Feed Supplement | A010395 |
| Assault | P006025 |
| ASSETT | P004862 |
| Bio-Cox 120G | A008279 |
| CROP CARE PHORATE 20 G | P004079 |
| CYCARB 250 ANTICOCCIDIAL PREMIX | A006048 |
| Disect | P004851 |
| ECZEMA CREAM | A002590 |
| EQUEST | A007279 |
| Extender Max | A009463 |
| FELEX PLUS ALL WORMER PASTE FOR CATS | A005988 |
49
Next Page →
✨ LLM interpretation of page content
🏥
Consent to the Distribution of New Medicines
(continued from previous page)
🏥 Health & Social Welfare14 October 2016
Medicines, Distribution, Consent, Revolade, Eltrombopag
- SARAH READER, Acting Group Manager, Medsafe, Ministry of Health
🌾 Removal of Trade Name Products From the Register of Trade Name Products
🌾 Primary Industries & ResourcesAgricultural Compounds, Veterinary Medicines, Product Removal, Trade Name Products
NZ Gazette 2016, No 95